The Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase, Florence, Italy, in collaboration with Procarta ltd, Norwich, England, and University of East Anglia, Norwich, England, and Nanovector, Torin, Italy, are looking to recruit and experienced researcher.
An amazing podcast that MUST be heard!
Fight back against MRSA to be started with a sniff novel – Procarta technology to disable killer bacteria in a nasal spray.
The Generating Antibiotics Incentive Now (GAIN) Act was signed into law in 2011 by President Obama.
The European patent office has granted Procarta a patent on the snare™ platform.
Two clear and stark warnings have been delivered concerning the threat of antibiotic resistance on our societies.
The Norwich Research Park is developing into an international centre for biotechnology, specializing in microbiology and plant bioscience.
Procarta has received grant-funding to develop its proprietary platform to investigate the effect of the human microbiota on health.
Procarta is pleased to announce that Dr. Kostas Hatzixanthis has joined the company as Director of Research with a mandate to prepare for preclinical trials and project manage EU collaborations.
Procarta’s Chairman, Dr. David Knowles, and CSO, Dr. Michael McArthur, will be attending the forthcoming ‘Superbugs and Superdrugs’ conference to be held in London on the 5th. and 6th. March